Literature DB >> 3144996

Inhibition of growth of HIV by human natural interferon in vitro.

O Yamada1, N Hattori, T Kurimura, M Kita, T Kishida.   

Abstract

The effect of human natural interferons (IFN) alpha, beta, and gamma on the replication of human immunodeficiency virus (HIV) strain LAV in T cell lines TALL-1 and CCRF-CEM and peripheral blood lymphocytes (PBL) was studied. The growth of TALL-1 was moderately sensitive to these IFN, whereas that of CCRF-CEM was resistant to them. The progeny virus yield of LAV in TALL-1 at the time of its peak was reduced to 10% of the control level at IFN-alpha, beta, and gamma concentrations of 3, 11, and 23 IU/ml, respectively. These concentrations of IFN-alpha, beta, and gamma did not affect the cell growth. In CCRF-CEM, IFN-alpha, beta, and gamma at the concentration of 50, 60, and 76 IU/ml reduced the progeny virus to 10% of the control level. The virus growth in PBL was more sensitive to IFN than that in CCRF-CEM. The progeny virus yield was reduced to 10% of the control level by IFN-alpha and beta concentrations of 5 IU/ml and less than 5 IU/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144996     DOI: 10.1089/aid.1988.4.287

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  20 in total

1.  Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Authors:  L A Pinto; V Blazevic; B K Patterson; C Mac Trubey; M J Dolan; G M Shearer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  HIV downregulates interferon-stimulated genes in primary macrophages.

Authors:  Seong-Heon Wie; Pinyi Du; Tiffany Q Luong; Steffney E Rought; Nadejda Beliakova-Bethell; Jean Lozach; Jacques Corbeil; Richard S Kornbluth; Douglas D Richman; Christopher H Woelk
Journal:  J Interferon Cytokine Res       Date:  2012-12-31       Impact factor: 2.607

4.  CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive.

Authors:  K F Copeland; P J McKay; J Newton; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  The IFITM proteins inhibit HIV-1 infection.

Authors:  Jennifer Lu; Qinghua Pan; Liwei Rong; Wei He; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

7.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.

Authors:  Frederik Graw; Roland R Regoes
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

9.  Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Authors:  Daniela Vendrame; Marion Sourisseau; Virginie Perrin; Olivier Schwartz; Fabrizio Mammano
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.

Authors:  Y Shirazi; P M Pitha
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.